Remdesivir

President Donald Trump's lawyer Rudy Giuliani has been discharged from the hospital after being treated for COVID-19, the disease caused by the CCP (Chinese Communist Party) virus. Photographs and video footage ...

The Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for a promising new drug ...

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for the treatment of adults ...

Remdesivir therapy, an experimental antiviral therapy that has been used to treat COVID-19, has no substantial effect on ...

The results of the ACTT-1 trial, which looked at the effectiveness of remdesivir as a treatment for COVID-19, have ...

President Donald Trump is "doing very well" and is beginning remdesivir therapy, an experimental antiviral therapy, White House physician ...

OTTAWA—Canada has now committed more than $1 billion to buy doses of COVID-19 vaccines after securing a fifth ...

IRVINE, Calif.—Doctors in Southern California say they are experimenting with different treatment combinations as they seek to find ...

Commentary Death rates in countries that rely on hydroxychloroquine (HCQ) for the treatment of COVID-19 appear to be ...

BRUSSELS—The European Union's executive said on Wednesday it had agreed to buy a limited supply of the COVID-19 ...

OTTAWA—Health Canada has approved the use of remdesivir to treat patients with severe symptoms of COVID-19. The federal ...

BERLIN—Gilead Sciences Inc plans to make more of its drug remdesivir available for Germany and Europe from autumn ...

A California-based company is charging hundreds of dollars per vial for a drug it created that's shown promise ...

NEW YORK—The U.S. government will ship more of Gilead Sciences Inc's antiviral treatment remdesivir to states experiencing an ...

Gilead Sciences will begin human trials of an inhaled version of remdesivir this week. "An inhaled formulation would ...

The Food and Drug Administration (FDA) warned on Monday that co-administering antiviral drug remdesivir with chloroquine phosphate or ...

An experimental drug recently touted for its effectiveness against COVID-19 showed a limited benefit for more moderately ill ...

The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences ...

The antiviral drug remdesivir sped up recovery from COVID-19, but researchers said the drug requires a supplement and ...

Federal health officials said some vials of remdesivir have already been sent to seven states, with plans to ...

Japanese authorities on Thursday approved remdesivir for treatment of COVID-19, the new disease caused by the CCP (Chinese Communist Party) ...

With the FDA approving Gilead’s Remdesivir as an emergency use treatment for the most acute cases of COVID-19, many people ...

Researchers changed the primary endpoint for a clinical trial testing remdesivir against COVID-19, a shift that provoked concerns ...

The Food and Drug Administration (FDA) granted an emergency authorization for Gilead Sciences’s remdesivir to treat the CCP ...

A rigorous trial sponsored by the U.S. government showed remdesivir has a clear impact on hospitalization time for ...

Gilead Sciences on Wednesday said it was aware of "positive data" from a study on remdesivir's effectiveness against ...

An antiviral drug tested against COVID-19 in patients in China did not quicken their improvement or prevent death, ...